Jiangsu Hengrui
LeaveRussia detail: Continue Operations
Jiangsu Hengrui Medicine (Jiangsu Hengrui) - Chinese pharmaceutical company. The headquarters is located in Lianyungang City. It was ranked 1,020th on the Forbes Global 2000 list of the world's largest public companies for 2021.
Decision trail
Decision date 06/12/2023 · Reference ↗
"Petrovax," formerly owned by Vladimir Potanin's "Interros" until last year, has reached an agreement with the Chinese company Jiangsu Hengrui regarding the supply and subsequent localization of several oncology drugs, including camrelizumab, belonging to the same class as the American MSD's "Keytruda."
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional